Very early rheumatoid arthritis as a predictor of remission: A multicentre real life prospective study

Annals of the Rheumatic Diseases

Volumn 72, Issue 6, 2013, Pages 858-862

  Gremese, Elisa ^a   Salaffi, Fausto ^b   Bosello, Silvia Laura ^a   Ciapetti, Alessandro ^b   Bobbio Pallavicini, Francesca ^c   Caporali, Roberto ^c   Ferraccioli, Gianfranco ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; METHOTREXATE; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; ALGORITHM; AMERICAN COLLEGE OF RHEUMATOLOGY CRITERIA; ARTICLE; COMBINATION CHEMOTHERAPY; COMORBIDITY; CONTROLLED STUDY; COST CONTROL; DAS28; DISABILITY SEVERITY; DISEASE CLASSIFICATION; DISEASE DURATION; EARLY INTERVENTION; FEMALE; FOLLOW UP; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; JOB PERFORMANCE; JOINT RADIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT REFERRAL; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REMISSION; RHEUMATOID ARTHRITIS; TERTIARY HEALTH CARE; VERY EARLY RHEUMATOID ARTHRITIS;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; EARLY MEDICAL INTERVENTION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; REFERRAL AND CONSULTATION; TERTIARY CARE CENTERS; TREATMENT OUTCOME;

EID: 84877634558     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-201456     Document Type: Article

References (23)

1. Jacoby RK, Jayson MIV, Cosh JA. Onset, early stages, and prognosis of rheumatoid arthritis: a clinical study of 100 patients with 11 years follow-up. BMJ 1970;2:96-100.
2. Lard LR, Visser H, Speyer I, et al. Early versus delayed treatment in patients with recent onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med 2001;111:446-51. (Pubitemid 33016415)
3. Mottönen T, Hannonen P, Markku K, et al., for the FIN-RACo Trial Group. Delay to institution of therapy and induction of remission using single drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis Rheum 2002;46:894-8. (Pubitemid 34303799)
4. van der Linden MPM, Le Cessie S, Raza K, et al. Long term impact of delay in assessments of patient with early arthritis. Arthritis Rheum 2010;62:3537-46.
5. Bosello S, Fedele AL, Peluso G, et al. Very early RA is the major predictor of major outcome: clinical ACR remission and radiographic non-progression. Ann Rheum Dis 2011;70:1292-5.
6. Vermeer M, Kuper HH, Hoekstra M, et al. Implementation of a treat to target strategy in very early rheumatoid arthritis: results of the Dutch Rheumatoid Arthritis Monitoring Remission Induction Cohort study. Arthritis Rheum 2011;63:2865-72.
7. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24. (Pubitemid 18091653)
8. Aletaha D, Neogi T, Silman A, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010;69:1580-8.
9. Pietrapertosa D, Tolusso B, Gremese E, et al. Diagnostic performance of anti-citrullinated peptide antibodies for the diagnosis of rheumatoid arthritis: the relevance of likelihood ratios. Clin Chem Lab Med 2010;48:829-34.
10. Fries JF, Spitz P, Kraines RG, et al. Measurement of patient outcome in arthritis. Arthritis Rheum 1980;23:137-45. (Pubitemid 10164318)
11. Ranza R, Marchesoni A, Calori G, et al. The Italian version of the functional disability index of the health assessment questionnaire. A reliable instrument for multicenter studies on rheumatoid arthritis. Clin Exp Rheumatol 1993;11:123-8. (Pubitemid 23155979)
12. Sokka T, Kautiainen H, Pincus T, et al. QUEST-RA. Work disability remains a major problem in rheumatoid arthritis in the 2000s: data from 32 countries in the QUEST-RA study. Arthritis Res Ther 2010;12:R42.
13. Pinals RS, Masi AT, Larsen RA. Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 1981;24:1308-15. (Pubitemid 11022943)
14. Van der Heijde D. How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 2000;27:261-3.
15. Puolakka K, Kautiainen H, Möttönen T, et al. Early suppression of disease activity is essential for maintenance of work capacity in patients with recent onset rheumatoid arthritis: five-year experience from the FINRACo trial. Arthritis Rheum 2005;52:36-41. (Pubitemid 40129230)
16. Puolakka K, Kautiainen H, Pekurinen M, et al. Monetary value of lost productivity over a five year follow up in early rheumatoid arthritis estimated on the basis of official register data on patients' sickness absence and gross income: experience from the FIN-RACo trial. Ann Rheum Dis 2006;65:899-904.
17. Grigor C, Capell H, Stirling A, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004;364:263-9. (Pubitemid 38942816)
18. Verstappen SM, Jacobs JW, van der Veen MJ, et al. Utrecht Rheumatoid Arthritis Cohort study group. Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial). Ann Rheum Dis 2007;66:1443-9. (Pubitemid 350032650)
19. Allaart CF, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, et al. FARR Study Group. Aiming at low disease activity in rheumatoid arthritis with initial combination therapy or initial monotherapy strategies: the BeSt study. Clin Exp Rheumatol 2006;24(6 Suppl. 43):S77-82. (Pubitemid 44696872)
20. Emery P, Kvien TK, Combe B, et al. Combination etanercept and methotrexate provides better disease control in very early (<=4 months) versus early rheumatoid arthritis (>4 months and <2 years): post hoc analyses from the COMET study. Ann Rheum Dis 2012;71:989-92.
21. Raza K, Stack R, Kumar K, et al. Delays in assessment of patients with rheumatoid arthritis: variations across Europe. Ann Rheum Dis 2011;70:1822-5.
22. Ferraccioli G, Gremese E. Pathogenetic, clinical and pharmaco-economic assessment in rheumatoid arthritis (RA). Intern Emerg Med 2011;6(Suppl.):S11-15.
23. Combe B, Landewe R, Lukas C, et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007;66:34-45. (Pubitemid 46044858)